Timber Pharmaceuticals Inc
WKN: A3DWN5 / ISIN: US8870802084BiopharmX vs Neothetics vs Galena
| eröffnet am: | 11.04.17 13:05 von: | Temesta |
| neuester Beitrag: | 24.04.21 23:13 von: | Lauranodya |
| Anzahl Beiträge: | 57 | |
| Leser gesamt: | 33668 | |
| davon Heute: | 3 | |
bewertet mit 0 Sternen |
||
|
Seite:
1
|
2
|
||
09.10.17 22:21
#26
Senseo2016
Die letzten 15 Minuten wurden nochmal
1 Mio Aktien gehandelt. Sollte morgen in der 1 Handelsstunde weiterlaufen
18.10.17 13:50
#27
Temesta
+++ Merger News +++ Watch Neothetics today +++
Schaut auf die Performance der letzten Tage und letzte News, Power on!!!
27.11.17 11:49
#32
majestrohc
Was
für eine Reaktion.... wurde alles besprochen.... jetzt ist warten angesagt... bin schon gut positioniert aber stehe auch nochmal tiefer bereit....
27.11.17 18:05
#34
majestrohc
kann
Dir die Frage nicht beantworten....sonst ist hier z.Z. ja auch nicht viel los, denke das niemand hier die Frage beantworten kann...
08.12.17 02:19
#38
Muusmann
NEWS: Termin draußen // Merger in 4 Wochen?
„The special meeting of stockholders of Neothetics will be held on January 5, 2018 at 8:00 a.m., local time, at the offices of DLA Piper LLP (US) located at 4365 Executive Drive, Suite 1100, San Diego, CA 92121“
http://www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
11.12.17 20:50
#39
Senseo2016
News
„The special meeting of stockholders of Neothetics will be held on January 5, 2018 at 8:00 a.m., local time, at the offices of DLA Piper LLP (US) located at 4365 Executive Drive, Suite 1100, San Diego, CA 92121“
http://www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
http://www.conferencecalltranscripts.org/no/summary2/?id=4400092
Denkt dran, wo der Kurs nach Closing stehen sollte: „Neothetics will issue and sell in a private placement transaction, or the Financing, $20 million of Neothetics common stock to existing Evofem Investors at a price per share equal to $2.0677“
28.02.18 06:42
#42
ERS77
Nachbörstlich +12% ist schon gewaltig
Hat jemand einenLink oder Infos zu dieser Explosion? Was sind hier die Kurstreiber? Danke
28.02.18 07:46
#45
ERS77
Drücken wir mal die Daumen
1.) Annual ROTH Conference Date: March 11st 2018
The ROTH Conference is basically a dick showing contest. 550 companies come from around the world and showcase their company and products. This should be great exposure for BPMX and if I am a betting man after the conference we will see higher volume and maybe a price jump.
2.) BPMX announces their earnings and possible FDA approval Date: March 22nd 2018
3.) Completion of BPX-01 and BPX-04, clinical trials Date: June 2018
The ROTH Conference is basically a dick showing contest. 550 companies come from around the world and showcase their company and products. This should be great exposure for BPMX and if I am a betting man after the conference we will see higher volume and maybe a price jump.
2.) BPMX announces their earnings and possible FDA approval Date: March 22nd 2018
3.) Completion of BPX-01 and BPX-04, clinical trials Date: June 2018
27.06.19 13:10
#50
Vassago
BPMX 0,74$ (-7%)
- vorbörslich aktuell bei 0,61$ (-15%)
- geringe Cashreichweite
https://biopharmx.investorroom.com/...X-04-for-Papulopustular-Rosacea
https://biopharmx.investorroom.com/...-Quarter-2020-Financial-Results
Seite:
1
|
1
|
2